Charles River Laboratories | CRL - 負債





負債 変化する 日付
Agilent USD 3.35B 0 2025-12
Align Technology USD 114.45M 6.82M 2025-12
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Bruker USD 2.04B 34.4M 2025-12
Cardinal Health USD 8.92B 111M 2026-03
Charles River Laboratories USD 2.57B 58.23M 2025-12
Cigna USD 30.9B 563M 2026-03
Concord Medical Services Hldg CNY 3.01B 27.15M 2023-06
CVS Health USD 78.34B 13.78B 2026-03
Danaher USD 18.48B 66M 2026-03
Dentsply International USD 2.33B 137M 2026-03
Elevance Health USD 31.84B 204M 2026-03
Humana USD 13.99B 1.62B 2026-03
Illumina USD 2.55B 23M 2025-12
Incyte USD 39.43M 982K 2026-03
Intrexon USD 0 13.82M 2024-06
IQVIA Holdings USD 15.83B 109M 2026-03
Laboratory Of America USD 6.53B 3.9M 2025-12
Lakefront Biotherapeutics EUR 6.44M 480K 2026-03
Lonza CHF 4.71B 915M 2024-12
McKesson USD 8.62B 1.17B 2025-12
Merck EUR 11.95B 152M 2025-12
Mettler Toledo International USD 2.15B 57.69M 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.73B 231M 2026-03
Quest Diagnostics USD 6.41B 179M 2026-03
Revvity USD 3.4B 29.2M 2025-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
United Therapeutics USD 200M 100M 2025-03
UnitedHealth USD 77.92B 472M 2026-03
Veradigm USD 200.33M 431K 2022-09
Waters USD 1.49B 4.92M 2025-12
West Pharmaceutical Services USD 202.8M 0 2026-03